Published in Ann Intern Med on June 03, 2008
Systematic review: comparing routine and selective invasive strategies for the acute coronary syndrome. Ann Intern Med (2008) 1.57
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg (2005) 4.95
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol (2013) 2.99
Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care (2009) 2.96
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83
Same-day discharge after percutaneous coronary intervention: a meta-analysis. J Am Coll Cardiol (2013) 2.80
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med (2006) 2.38
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol (2006) 1.94
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J (2008) 1.92
Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol (2010) 1.76
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. J Am Coll Cardiol (2005) 1.72
Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv (2012) 1.65
Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol (2011) 1.62
Limitations of the MEDLINE database in constructing meta-analyses. Ann Intern Med (2010) 1.48
Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension (2012) 1.46
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens (2014) 1.45
Predictors and Outcomes of Side-Branch Occlusion in Coronary Chronic Total Occlusion Interventions. J Invasive Cardiol (2016) 1.41
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes (2014) 1.41
Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013. Catheter Cardiovasc Interv (2014) 1.33
Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol (2011) 1.17
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med (2010) 1.17
Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol (2004) 1.16
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol (2010) 1.14
Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med (2007) 1.14
Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm (2010) 1.10
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med (2009) 1.07
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J (2011) 1.04
Cardiac resynchronization therapy in non-left bundle branch block morphologies. Pacing Clin Electrophysiol (2009) 1.02
Is clopidogrel cardiovascular medicine's double-edged sword? Circulation (2006) 1.01
Silent ischemia: clinical relevance. J Am Coll Cardiol (2012) 0.99
Intraoperative regional myocardial acidosis and reduction in long-term survival after cardiac surgery. J Thorac Cardiovasc Surg (2005) 0.96
Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm (2010) 0.93
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Am Heart J (2008) 0.91
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry. Clin Cardiol (2013) 0.90
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs (2007) 0.89
A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol (2006) 0.89
Impact of intraoperative myocardial tissue acidosis on postoperative adverse outcomes and cost of care for patients undergoing prolonged aortic clamping during cardiopulmonary bypass. Am J Surg (2008) 0.89
Fractional flow reserve: an updated review. Clin Cardiol (2014) 0.87
Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Am J Cardiovasc Drugs (2007) 0.87
Intracoronary shunt-induced endothelial cell damage in porcine heart. J Surg Res (2006) 0.86
The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev (2012) 0.86
Elevated red cell distribution width is associated with impaired reverse ventricular remodeling and increased mortality in patients undergoing cardiac resynchronization therapy. Congest Heart Fail (2011) 0.85
Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). Am J Cardiol (2005) 0.85
Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol (2007) 0.85
Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy. Am J Cardiol (2010) 0.84
Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol (2007) 0.84
Quantitative angiography in South Asians reveals differences in vessel size and coronary artery disease severity compared to Caucasians. Am J Cardiovasc Dis (2011) 0.84
Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med (2013) 0.83
Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]). Am J Cardiol (2012) 0.83
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol (2012) 0.82
Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention? J Am Coll Cardiol (2016) 0.82
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines. Clin Cardiol (2011) 0.81
Acute coronary syndrome (unstable angina and non-ST elevation MI). BMJ Clin Evid (2009) 0.80
The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med (2008) 0.79
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J (2008) 0.79
2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults with Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2016) 0.79
Platelet activation: yet another strike against routine TRANSFUSION. Eur Heart J (2010) 0.78
The AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusion (ACE-CTO) Study. J Invasive Cardiol (2015) 0.77
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation (2007) 0.77
Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials. Catheter Cardiovasc Interv (2014) 0.77
Secondary prevention of stroke: can we do better than aspirin? Lancet Neurol (2010) 0.76
Meta-analysis of stroke after transradial versus transfemoral artery catheterization. Int J Cardiol (2013) 0.76
Does volume help predict outcome in surgical disease? Adv Surg (2005) 0.76
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol (2006) 0.76
Statins and cognitive function: an updated review. Curr Cardiol Rep (2015) 0.76
Reply: aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol (2014) 0.75
Reply: safety of same-day discharge after percutaneous coronary intervention: what is the level of evidence? J Am Coll Cardiol (2014) 0.75
Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization. Tex Heart Inst J (2015) 0.75
Paving the coronaries with stents: okay in acute coronary syndromes? Clin Cardiol (2011) 0.75
Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J (2007) 0.75
Images in Cardiovascular Medicine. Don't turn your head! Circulation (2009) 0.75
Novel strategies for the diagnosis and treatment of arterial access perforations. Catheter Cardiovasc Interv (2012) 0.75
Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease. J Am Heart Assoc (2013) 0.75
Designing the ideal risk model for acute coronary syndromes--is simple better than complex? Am Heart J (2007) 0.75
Treatment of hypertension: lower is better, or is it? Hypertension (2012) 0.75
Non ST-elevation acute coronary syndrome. BMJ Clin Evid (2010) 0.75
Routine vs selective invasive strategies in acute coronary syndromes. JAMA (2005) 0.75
Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Indian Heart J (2009) 0.75
Reply: Mechanical Thrombectomy for Ischemic Stroke. J Am Coll Cardiol (2016) 0.75
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol (2017) 0.75
Clopidogrel and coronary stents: risks and benefits. Curr Atheroscler Rep (2008) 0.75
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness. Am Surg (2015) 0.75
Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med (2009) 0.75
Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer. Breast J (2010) 0.75
The Hidden Players. JACC Cardiovasc Interv (2016) 0.75
Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med (2007) 0.75
The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis. JACC Cardiovasc Interv (2016) 0.75
Drug-eluting stents versus bare-metal stents for saphenous vein graft revascularisation: A meta-analysis of randomised trials. EuroIntervention (2017) 0.75
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes (2017) 0.75
Reply: Meta-Analysis of Strategies for Patients With Multivessel Disease Undergoing Percutaneous Coronary Intervention: Does the Timing of Staged Procedures Matter? JACC Cardiovasc Interv (2017) 0.75
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. J Hypertens (2017) 0.75